# FDA PreCheck Integration Architecture
**Based on Executive Order 14293 & FDA PreCheck Pilot Program Structure**

**Last Updated: 2026-03-11 16:00 MDT**

---

## EXECUTIVE ORDER 14293 CONTEXT

**Purpose:** "Regulatory Relief to Promote Domestic Production of Critical Medicines"

**FDA's Mandate:**
- Streamline review of domestic pharmaceutical manufacturing
- Eliminate unnecessary regulatory requirements
- Maximize review timeliness and predictability

**PreCheck Program Response:** Two-phase approach to facilitate new U.S. drug manufacturing facilities

---

## PRECHECK TWO-PHASE STRUCTURE

### Phase 1: Facility Readiness Phase
**Timeline:** Facility design → Construction → Pre-production  
**FDA Communication:** Frequent, at critical development stages  
**Key Deliverables:**
- Facility design documentation (site layout, equipment specs)
- Pharmaceutical Quality System (PQS) elements
- Quality Management Maturity (QMM) practices
- Type V Drug Master File (DMF) with facility-specific information

**Goal:** Ensure facility is designed for compliance before construction/validation begins

**What FDA Evaluates:**
- Site selection & location
- Layout & workflow (contamination prevention)
- HVAC/cleanroom classification
- Equipment specifications & qualification plan
- Quality management system maturity
- Personnel training & competency

### Phase 2: Application Submission Phase
**Timeline:** After Facility Readiness approved  
**FDA Communication:** Pre-application meetings + early feedback  
**Key Deliverables:**
- Chemistry, Manufacturing, Controls (CMC) section of drug application
- Validation Summary Report (VSR) from facility
- Quality Overall Summary
- Environmental monitoring data

**Goal:** Streamline CMC review through pre-submission meetings & early feedback

**What FDA Reviews:**
- Drug substance manufacturing process
- Drug product manufacturing process
- Equipment suitability for the drug being manufactured
- Environmental monitoring results
- In-process controls & acceptance criteria
- Stability data & shelf-life

---

## HOW GXP PLANNER MAPS TO PRECHECK PHASES

### GXP Module → PreCheck Phase Alignment

| GXP Module | PreCheck Phase | What It Generates | FDA Touchpoint |
|---|---|---|---|
| **Equipment Spec** | Facility Readiness | Equipment list + specs | Type V DMF section |
| **Layout Design** | Facility Readiness | Site operations layout | Type V DMF section |
| **Validation Lifecycle** | Facility Readiness + Application | URS/FRS/IQ/OQ/PQ/VSR | Type V DMF + CMC attachment |
| **Risk Management** | Facility Readiness | Risk assessments per ICH Q9 | Type V DMF section |
| **Readiness Forecasting** | Both phases | Milestone tracking (design → construction → pre-prod) | Pre-application meeting agenda |
| **Compliance Dashboard** | Both phases | Real-time compliance proof (test results, audit trail) | PreCheck submission package |

---

## PRECHECK FACILITY READINESS PHASE (GXP FOCUS)

**GxP Planner IS the Facility Readiness tool.**

### Stage 1: Design Approval (Weeks 1–4)
**What customer needs to submit to FDA PreCheck:**

1. **Facility Design Documentation**
   - Location & site selection justification
   - Site operations layout (equipment placement, workflow)
   - Cleanroom classification plan (ISO 14644)
   - HVAC specification & design
   - Utility systems (water, power, waste)
   - Personnel flow & change areas

   **GxP Planner Deliverable:** Layout design artifact + compliance checklist

2. **Equipment Specifications**
   - Equipment list (500+ types database)
   - Equipment suitability for drug/product
   - Qualification plan (IQ/OQ/PQ approach)
   - Critical process parameters (CPPs)
   - Critical quality attributes (CQAs)

   **GxP Planner Deliverable:** Equipment spec artifact + qualification roadmap

3. **Preliminary Pharmaceutical Quality System (PQS)**
   - Quality objectives
   - Management responsibility
   - Resource management
   - Product realization (process design, validation)
   - Measurement, analysis, improvement

   **GxP Planner Deliverable:** PQS maturity assessment + gap analysis

### Stage 2: Pre-Construction Checkpoint (Week 6–8)
**FDA Feedback:** "Approved to proceed" or "Provide additional info"

**If Approved:** Proceed to construction with confidence. FDA engaged + aligned.
**If Not:** Rework design + resubmit. Early feedback prevents costly mid-construction changes.

### Stage 3: Pre-Production Readiness (Week 12+)
**What customer submits:**
- Completed facility (construction finished)
- Equipment installed & qualified (IQ/OQ complete)
- Validation testing underway (PQ in progress)
- QC lab ready (analytical methods validated)
- Training documentation (personnel records)
- Type V DMF (comprehensive facility info)

**GxP Planner Deliverable:** Pre-production readiness report + checklist

---

## TYPE V DRUG MASTER FILE (DMF) GENERATION

**GxP Planner auto-generates Type V DMF content from:**
- Equipment specifications (module 1)
- Facility layout (module 2)
- Validation lifecycle status (module 3)
- Risk assessments (module 4)
- Readiness forecast (module 5)
- Compliance dashboard (module 6)

### Type V DMF Sections (Auto-Populated by GxP)

**I. Facility Description**
- Location, size, design, layout (from layout design module)
- Cleanroom classification, HVAC specs (from compliance dashboard)

**II. Equipment & Utilities**
- Equipment list with specs (from equipment spec module)
- Utility systems validation status (from validation module)
- Critical equipment qualification approach (from validation module)

**III. Pharmaceutical Quality System**
- Quality policies & objectives (auto-prompt in setup)
- Management structure & responsibilities (from team management, Wave 2)
- Risk management approach (from risk module + ICH Q9)
- Change control process (from change control, Wave 2)
- Document control (from compliance dashboard)

**IV. Quality Management Maturity (QMM) Practices**
- Maturity assessment (scoring from compliance dashboard)
- Continuous improvement examples (from risk mitigation tracking)
- Data integrity & security (from 21 CFR Part 11 audit log)

**V. Validation & Testing**
- Validation Master Plan (auto-generated from validation module)
- IQ/OQ/PQ status & results (from test execution)
- Environmental monitoring plan (from layout design)
- Analytical method validation (linked to Wave 2 LIMS integration)

**VI. Personnel Training**
- Training records & competency (training module, Wave 2)
- GMP certification status (from team module, Wave 2)

**VII. Change History**
- Equipment changes, process changes, facility modifications (from change control log, Wave 2)

---

## PRECHECK COMMUNICATION WORKFLOW

**GxP Planner enables frequent FDA communication:**

### Pre-Application Meeting #1 (Week 4)
**GxP Planner generates:** Design approval submission package
- Equipment specs + suitability justification
- Facility layout + contamination prevention strategy
- Preliminary PQS assessment
- Risk management approach (ICH Q9)

**Question for FDA:** "Is our facility design adequate for PreCheck approval?"

### Pre-Application Meeting #2 (Week 8)
**GxP Planner generates:** Pre-construction status report
- Design finalized
- Equipment ordered (lead time confirmed)
- Regulatory timeline (readiness forecast)
- Construction schedule
- Risk mitigation tracking

**Question for FDA:** "Are we ready to begin construction?"

### Pre-Application Meeting #3 (Week 12)
**GxP Planner generates:** Pre-production readiness package
- Facility construction complete
- Equipment installed (IQ/OQ results)
- Validation testing status (PQ progress)
- QC lab ready (analytical methods)
- Type V DMF (comprehensive)

**Question for FDA:** "Are we ready for pre-approval inspection (PAI)?"

### Pre-Approval Inspection (PAI) Coordination (Week 14+)
**GxP Planner generates:** PAI readiness checklist
- Compliance dashboard (all tests passing, 847 automated tests)
- Audit trail (21 CFR Part 11 immutable log)
- Personnel training records
- Change control history
- Environmental monitoring data

**FDA evaluates:** Facility compliance with cGMP + PreCheck commitments

---

## CRITICAL: FDA EXPERT CONSULTATION DURING BUILD

**GxP Planner cannot be built correctly without FDA input.**

### What FDA Needs to Validate (During Build)

**Phase 1a (Database foundation):** ✅ Build can start
- Schema design for audit trails (21 CFR Part 11)
- RLS for data segregation
- Facility/equipment/test data model

**Phase 1b (Facility + Validation engines):** ⚠️ FDA consultation needed
- URS template matches PreCheck requirements
- FRS covers all PreCheck documentation needs
- Validation lifecycle aligns with 21 CFR 211 requirements

**Phase 2a (Risk + Readiness engines):** ⚠️ FDA consultation needed
- Risk management framework matches ICH Q9
- Readiness forecasting milestones align with PreCheck phases
- Critical path identification for facility buildout

**Phase 2b (Equipment database):** ⚠️ FDA consultation needed
- Equipment specifications include all cGMP-relevant attributes
- Equipment suitability assessment criteria
- Critical parameters & attributes per equipment type

**Phase 2c (Layout design tool):** ⚠️ FDA consultation needed
- ISO 14644 compliance checking logic
- Contamination prevention rules engine
- HVAC/workflow/personnel movement validation

**Phase 2d (Polished UI + Onboarding + Manuals start):** ⚠️ FDA consultation needed
- Customer guidance for PreCheck submission
- Type V DMF generation rules
- Pre-application meeting preparation templates

### Recommendation: Bring FDA Regulatory Expert Onboard

**Who:** FDA PreCheck program manager or equivalent regulatory affairs expert

**When:** Week 1 (Phase 1b starts)

**Role:** 
- Review URS/FRS templates (does GxP cover PreCheck requirements?)
- Validate risk framework (ICH Q9 implementation correct?)
- Review equipment database (comprehensive? compliant criteria?)
- Validate layout compliance logic (contamination prevention rules accurate?)
- Review Type V DMF generation (complete? accurate? FDA-approvable?)
- Provide official guidance document for customers (how to use GxP for PreCheck)

**Commitment:** 4–6 hours/week during Weeks 1–13 (code review, Q&A, validation)

**Cost:** Negotiate as part of build budget or separate consulting agreement

**Impact:** 
- Eliminates regulatory risk in product design
- Differentiates GxP from competitors ("FDA-aligned")
- Accelerates customer PreCheck submissions ("trusted by FDA")
- Becomes credibility advantage for sales

---

## PRECHECK COMPLIANCE CHECKLIST (For Build Team)

**Every phase must answer: "Does this advance PreCheck capability?"**

### Phase 1a: Database Foundation
- [ ] URS tracking for PreCheck requirements
- [ ] DMF section tracking (which module generates which section?)
- [ ] 21 CFR Part 11 audit trail architecture
- [ ] Facility/equipment/test data model supports PreCheck types

### Phase 1b: Facility + Validation Engines
- [ ] URS template covers PreCheck Phase 1 requirements
- [ ] FRS template covers equipment/facility/PQS documentation
- [ ] Validation lifecycle matches 21 CFR 211 (IQ/OQ/PQ sequencing)
- [ ] Risk management framework matches ICH Q9
- [ ] Readiness forecasting tracks PreCheck milestones

### Phase 2a: Risk + Readiness Engines
- [ ] Risk scoring aligns with FDA ICH Q9 guidance
- [ ] Readiness forecast shows Facility Readiness Phase timeline
- [ ] Pre-application meeting milestones identified
- [ ] Critical path (design → construction → pre-production) tracked

### Phase 2b: Equipment Database
- [ ] 500+ equipment types include PreCheck-relevant attributes
- [ ] Equipment suitability assessment per drug/product type
- [ ] Critical parameters & attributes documented
- [ ] Lead times tracked (regulatory path impacts timeline)

### Phase 2c: Layout Design Tool
- [ ] ISO 14644 compliance rules implemented
- [ ] Contamination prevention validation rules active
- [ ] HVAC specification guidance provided
- [ ] Personnel flow/gowning assessment enabled

### Phase 2d: Polished UI + Onboarding + Manuals
- [ ] PreCheck submission wizard built
- [ ] Type V DMF generation tested with real facility scenario
- [ ] Pre-application meeting preparation templates provided
- [ ] Customer guidance document for PreCheck navigation

### Phase 3: Integration + Hardening + Compliance Dashboard
- [ ] Compliance dashboard shows PreCheck readiness status
- [ ] 847 tests include PreCheck scenario validation
- [ ] Audit trail shows regulatory compliance proof
- [ ] Manuals include PreCheck-specific guidance

### Phase 4: Final Validation + Deployment
- [ ] FDA expert sign-off on PreCheck alignment
- [ ] Customer PreCheck scenario tested end-to-end
- [ ] Type V DMF generation QA tested (accuracy, completeness)
- [ ] Regulatory guidance document finalized

---

## TIMELINE IMPACT: FDA CONSULTATION

**If FDA expert engaged Week 1:**
- ✅ Phases 1b–2d validated against PreCheck requirements (no rework)
- ✅ Type V DMF generation built correctly first time
- ✅ Customer guidance document produced (marketing asset)
- ✅ Product credibility: "FDA-aligned from day 1"
- ✅ Regulatory risk eliminated

**If FDA expert NOT engaged:**
- ❌ Weeks 10–12: FDA review of Phase 2 output reveals misalignment
- ❌ Rework required (cost: 10–20 tokens, 1–2 weeks)
- ❌ Timeline slips (June 11 → June 25)
- ❌ Product credibility: "Built without FDA input" (harder sell)
- ❌ Regulatory risk remains until customer deployment

**Recommendation: Engage FDA expert from Week 1. Cost is high, but risk mitigation is worth it.**

---

## SALES & POSITIONING IMPACT

**"FDA-Aligned PreCheck Advantage"**

**Customer pitch:**
"GxP Planner is built with FDA PreCheck Pilot Program in mind. Each module generates the documentation FDA needs:

- **Facility Design → PreCheck Type V DMF**
- **Equipment Specs → PreCheck equipment section**
- **Validation Results → PreCheck CMC attachment**
- **Compliance Dashboard → PreCheck readiness proof**

Compare: Traditional approach (3–4 consultants, 6 months, $500K) vs. GxP Planner (self-service, 8 weeks, $50K).

Your facility moves from design to FDA-approved in half the time. That's PreCheck acceleration."

---

## IMPLEMENTATION ROADMAP

### MVP (June 11)
- ✅ Equipment spec + layout (PreCheck facility design inputs)
- ✅ Validation lifecycle (PreCheck equipment qualification path)
- ✅ Risk management (PreCheck PQS & risk assessment proof)
- ✅ Readiness forecast (PreCheck timeline tracking)
- ✅ Compliance dashboard (PreCheck submission readiness)

### Wave 2 (July–Sept)
- PreCheck submission wizard (guided Type V DMF generation)
- Pre-application meeting templates (agenda + talking points)
- CMC section drafting (chemistry, manufacturing, controls)
- Regulatory correspondence tracker (FDA communications)

### Wave 3 (Oct+)
- DMF submission integration (direct API to FDA eSTAR, if available)
- PAI preparation checklist (final readiness before inspection)
- Post-approval change management (aligned with FDA requirements)
- Continuous manufacturing pathway (ICH Q13 support)

---

## BOTTOM LINE

**PreCheck is not a feature. It's the entire product architecture.**

GxP Planner solves PreCheck, not just generic validation.

Every module is designed to:
1. Generate PreCheck documentation (Type V DMF sections)
2. Track PreCheck milestones (Facility Readiness Phase → Application Phase)
3. Enable FDA communication (pre-application meetings, submission packages)
4. Prove compliance (847 tests, audit trail, regulatory proof)

**This is the moat. Competitors can't replicate this without understanding PreCheck deeply.**

---

## WHAT BOBBY NEEDS TO DECIDE

1. **Engage FDA expert Week 1?** (Yes = cost + credibility. No = risk of rework.)
2. **PreCheck positioning first?** (Yes = higher intent customers, smaller TAM. No = broader but weaker messaging.)
3. **Type V DMF auto-generation in MVP?** (Yes = complexity, powerful feature. No = Wave 2, simpler MVP.)

**Recommendation:**
- ✅ Engage FDA expert Week 1 (critical path)
- ✅ PreCheck positioning first (better customers, better pricing)
- ✅ Type V DMF auto-generation in MVP Phase 2d (customer-facing killer feature)

